Stocktoria
NEUROONE MEDICAL TECHNOLOGIES Corp NMTC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2012-11-09
NEUROONE MEDICAL TECHNOLOGIES Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $9.1M | $3.5M | $2.0M | $171,169 | $178,146 |
| Gross profit | $5.1M | $1.1M | $456,517 | -$70,794 | -$97,749 |
| R&D expense | $5.0M | $5.1M | $6.9M | $4.9M | $3.9M |
| SG&A expense | $7.4M | $7.9M | $6.9M | $7.0M | $6.3M |
| Operating income | -$4.2M | -$11.9M | -$12.0M | -$10.0M | -$10.2M |
| Interest expense | — | — | — | — | $3,053 |
| Income tax | — | — | — | — | -$271,122 |
| Net income | -$3.6M | -$12.3M | -$11.9M | -$10.0M | -$9.9M |
| EPS (diluted) | $-0.09 | $-0.46 | $-0.65 | $-0.63 | $-0.93 |
| Operating cash flow | -$2.8M | -$11.0M | -$12.9M | -$7.5M | -$8.6M |
| Free cash flow | -$2.9M | -$11.1M | -$13.3M | -$7.8M | -$8.7M |
| Cash & equivalents | $6.6M | $1.5M | $5.3M | $8.2M | $6.9M |
| Inventory | $2.2M | $2.6M | $1.7M | $704,538 | $98,287 |
| Total assets | $10.8M | $5.4M | $8.1M | $12.8M | $7.9M |
| Total liabilities | $3.7M | $4.5M | $1.8M | $3.2M | $1.4M |
| Shareholders' equity | $7.1M | $822,013 | $6.2M | $9.6M | $6.6M |
Source: SEC EDGAR filings · CIK 0001500198 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.